CareRx Corporation (TSX:CRRX)
Canada
· Delayed Price · Currency is CAD | Market Cap | 234.75M |
| Revenue (ttm) | 370.24M |
| Net Income (ttm) | 26.13M |
| Shares Out | 63.45M |
| EPS (ttm) | 0.41 |
| PE Ratio | 9.02 |
| Forward PE | 18.20 |
| Dividend | 0.08 (2.16%) |
| Ex-Dividend Date | Mar 19, 2026 |
| Volume | 1,304 |
| Average Volume | 31,908 |
| Open | 3.710 |
| Previous Close | 3.700 |
| Day's Range | 3.690 - 3.710 |
| 52-Week Range | 2.510 - 4.000 |
| Beta | 0.66 |
| RSI | 46.39 |
| Earnings Date | May 6, 2026 |
About CareRx
CareRx Corporation, together with its subsidiaries, provides pharmacy services to senior homes and other congregate care settings in Canada. The company also offers medication management services. It serves long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is based in Toronto, Canada. [Read more]
Financial Performance
Financial StatementsNews
CareRx Welcomes Stability in Long-Term Care Pharmacy Funding in Ontario
Toronto, Ontario--(Newsfile Corp. - April 16, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate ...
CareRx Corporation Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 15, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate ...
CareRx Earnings Call Transcript: Q4 2025
Q4 2025 saw strong revenue and margin growth, with full-year net income positive for the first time. Bed count and operational efficiency improved, leverage declined, and capital returns to shareholders increased. Outlook targets further bed growth and margin expansion.
CareRx Announces Q1 2026 Dividend
Toronto, Ontario--(Newsfile Corp. - March 4, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate c...
CareRx Reports 2025 Year-End and Fourth Quarter Results
Toronto, Ontario--(Newsfile Corp. - March 4, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate c...
CareRx Corporation to Host Annual and Fourth Quarter 2025 Financial Results Conference Call on Thursday, March 5, 2026 at 8:30 a.m. ET
Toronto, Ontario--(Newsfile Corp. - February 25, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company") today announced it will host a conference call to discuss its annual and fourth quar...
CareRx Announces Q4 2025 Dividend
Toronto, Ontario--(Newsfile Corp. - December 15, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congrega...
CareRx Earnings Call Transcript: Q3 2025
Q3 2025 saw revenue of CAD 93.2M, Adjusted EBITDA of CAD 8.3M, and net income of CAD 1.6M, with margin expansion and strong cash flow. Bed growth and efficiency initiatives support a positive outlook, with robust organic and M&A opportunities ahead.
CareRx Reports Results for the Third Quarter of 2025
Toronto, Ontario--(Newsfile Corp. - November 3, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregat...
CareRx Corporation to Host Third Quarter 2025 Financial Results Conference Call on Tuesday, November 4, 2025 at 8:30 a.m. ET
Toronto, Ontario--(Newsfile Corp. - October 24, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company") today announced it will host a conference call to discuss its third quarter 2025 fina...
CareRx Initiates Quarterly Dividend and Receives Regulatory Approval for Renewal of its Normal Course Issuer Bid
Toronto, Ontario--(Newsfile Corp. - September 15, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congreg...
CareRx Initiates Quarterly Dividend
Toronto, Ontario--(Newsfile Corp. - September 15, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congreg...
CareRx Earnings Call Transcript: Q2 2025
Q2 2025 revenue was $91.4M, with adjusted EBITDA up 7% year-over-year and net income of $561K. 3,000 new beds were onboarded, supporting growth targets and margin expansion, while capital allocation remains focused on bed growth, efficiency, and share buybacks.
CareRx Reports Results for the Second Quarter of 2025
Bed Growth Delivers Ending Bed Count 91,062 Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy servi...
CareRx Corporation to Host Second Quarter 2025 Financial Results Conference Call on Thursday, July 31, 2025 at 8:30 a.m. ET
Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company") today announced it will host a conference call, including a slide presentation, to discu...
CareRx Earnings Call Transcript: Q1 2025
Q1 2025 saw stable revenue at CAD 89.6M, a 4.5% rise in adjusted EBITDA, and a return to net income. New beds and a major facility consolidation position the business for growth, with cost efficiencies and further bed wins expected in the coming quarters.
CareRx Reports Results for the First Quarter of 2025
Return to Growth Toronto, Ontario--(Newsfile Corp. - May 7, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and oth...
CareRx Corporation to Host First Quarter 2025 Financial Results Conference Call on Wednesday, May 7, 2025 at 10:30 a.m. ET
Toronto, Ontario--(Newsfile Corp. - April 30, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or "the Company") today announced it will host a conference call, including a slide presentation, to disc...
CareRx Earnings Call Transcript: Q4 2024
Q4 2024 saw revenue and adjusted EBITDA growth year-over-year, with improved cash flow and a reduced net loss. Debt restructuring and operational efficiencies position the company for robust bed growth and margin expansion in 2025.
CareRx Reports Results for the Fourth Quarter of 2024
Well Positioned for the Next Stage of Growth Toronto, Ontario--(Newsfile Corp. - March 5, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy serv...
CareRx Corporation to Host Fourth Quarter 2024 Financial Results Conference Call on Wednesday, March 5, 2025 at 8:30 a.m. ET
Toronto, Ontario--(Newsfile Corp. - February 25, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or "the Company") today announced it will host a conference call, including a slide presentation, to ...
CareRx Earnings Call Transcript: Q3 2024
Q3 2024 saw revenue of CAD 92.8M and adjusted EBITDA of CAD 7.8M, with margin improvements and a reduced net loss. A new fulfillment center in BC and nearly 3,000 new beds secured for 2025 support growth targets and double-digit EBITDA margins.
CareRx Earnings Call Transcript: Q2 2024
Q2 2024 saw revenue of CAD 92M and adjusted EBITDA of CAD 7.5M, with margin improvement and a net loss due to non-cash items. Operational efficiencies, a new supply agreement, and a robust growth pipeline support stable margins and future expansion.